Christopher L. Heran

pH-Dependent Dissolution in Vitro and Absorption in Vivo of Weakly Basic Drugs: Development of a Canine Model

Rong Zhou, Paul Moench, Christopher L. Heran et al. · Pharmaceutical Research · 2005 · 117 citations

Pharmaceutical Science, Pharmacological Study, Medicine +9

Optimization of the β-Aminoester class of factor Xa inhibitors. part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity

Kevin R. Guertin, Charles J. Gardner, Scott I. Klein et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 52 citations · Full text

Thrombosis, Medicinal Chemistry, Biochemistry +10

Low-Molecular-Weight Heparin (Fragmin) and Thrombin Active-Site Inhibitor (Argatroban) Compared in Experimental Arterial and Venous Thrombosis and Bleeding Time

William A. Schumacher, Christopher L. Heran, Thomas E. Steinbacher · Journal of Cardiovascular Pharmacology · 1996 · 46 citations

Carbopol-mediated paracellular transport enhancement in Calu-3 cell layers

Lianli Li, Neil Mathias, Christopher L. Heran et al. · Journal of Pharmaceutical Sciences · 2005 · 43 citations

Signal Transduction, Calu-3 Cell Layers, Membrane Transport +8

Identification and Initial Structure−Activity Relationships of a Novel Class of Nonpeptide Inhibitors of Blood Coagulation Factor Xa

Scott I. Klein, Mark Czekaj, Charles J. Gardner et al. · Journal of Medicinal Chemistry · 1998 · 39 citations · Full text

Vitro Potency, Pharmacotherapy, Initial Structure−activity Relationships +20